novartis ceo: chasing cures | mad money | cnbc
Published 5 years ago • 2.4K plays • Length 7:54Download video MP4
Download video MP3
Similar videos
-
8:47
novartis ceo: prescriptions in the pipeline | mad money | cnbc
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
2:04
cramer’s stop trading: novartis
-
6:37
novocure ceo: electrifying treatment | mad money | cnbc
-
1:06:36
josh brown says "what this stock is doing today is sort of bizarre!"
-
12:35
the pullback in microsoft is ridiculous, says jim cramer
-
4:09
it's not surprising that market volatility caught up to us, says newedge wealth's cameron dawson
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
4:19
focus remains on r&d to drive growth of blockbuster drugs, says novartis ceo
-
7:34
gw pharmaceuticals ceo: cannabis as a cure | mad money | cnbc
-
9:35
eli lilly's miss explanation is 'totally opaque', says jim cramer
-
4:17
novartis ceo: we expect our six key drugs to grow ahead of analyst expectations
-
2:32
cramer's stop trading: estee lauder
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
11:17
pfizer ceo albert bourla goes one-on-one with jim cramer
-
7:28
gw pharmaceuticals ceo: defining cbd and thc-based drugs | mad money | cnbc
-
6:00
biotelemetry ceo: cloud-based health | mad money | cnbc
-
1:39
cramer's mad dash: mastercard
-
6:32
first data corp. ceo: chasing fast growth | mad money | cnbc
-
6:12
novartis ceo: expect continued growth in 2023